This is an excellent quarterly. They're making great strides forward and I must admit that I am more than pleasantly surprised.
**Assumed that trials were bogged down, but happy to be wrong.
Now while we're on a roll, lets bring on the news about a major pharma coming on board.
Excellent report!!!